Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Compass enters the final stretch before its November 6 results with short sellers rebuilding positions aggressively, options traders suddenly protective, and the Street cutting targets even as the consensus rating nominally stays buy.
The positioning story is the sharpest angle this week. Short interest in COMP has jumped 20% over the past week to 10.2% of free float, and is up 46% over the past month, the kind of acceleration that marks a deliberate directional bet rather than routine hedging. The absolute level is high, and the trajectory is steeper than anything seen in the prior 30-day window. Options traders amplified the message on Tuesday: the put/call ratio spiked to 0.51 on October 13, nearly three standard deviations above its 20-day average of 0.32. That is the most defensive single-day reading in the options market this year, almost double the prior day's 0.32, and a clear break from the call-heavy posture that had dominated the past month. The borrow market tells a less alarming story. Availability is loose at 918% of short interest, meaning there are roughly nine shares available to borrow for every one already borrowed. Cost to borrow has edged up about 19% on the week to 0.52%, but that remains a negligible rate, and the 52-week peak utilisation of only 19% confirms this is not a stock under structural borrow pressure. Bears can build positions cheaply. The conjunction of rising short interest and a sharp PCR spike in a single session is the standout tension.
The Street is more cautious than the headline consensus rating implies. Wells Fargo cut its target from $13 to $10 on Monday, staying at equal-weight, bringing the bank below the current $8.81 price on a valuation basis. Citizens initiated at market outperform Wednesday with a $11 target, which at least sits above the market. Goldman Sachs and Barclays both lifted targets in August after the Q2 print, to $12 and $16 respectively, but those levels now look distant given the stock's 16% slide over the past month. The mean target across the analyst group is $14.62, which nominally implies 66% upside, though the recent pattern of cuts suggests the Street is revising that gap lower rather than growing more confident in it. Valuation has compressed: the price/earnings multiple has fallen by 2.1 points over 30 days to 10.4 times, and price/book has dropped 0.41 points to 1.9 times. The EV/EBITDA of 6.3 times is the multiple most relevant to Compass's profitability story, and it has barely moved, reflecting that enterprise value is falling roughly in line with earnings expectations. Factor scores add nuance: the 90-day EPS momentum rank is strong at the 76th percentile, and forward EPS year-on-year improvement sits at the 83rd percentile, suggesting the underlying earnings revision trend remains constructive. But the short score rank sits at only the 21st percentile, consistent with growing bearish pressure in the lending market.
The bull case rests on the 37,000-agent platform, a potential to double EBITDA from the current base, and high-teens gross transaction value growth. The bear case centres on the ongoing legal dispute with Zillow over Private Exclusives, the risk of concentration in the House acquisition, and a market share of just 3.2% in a fragmented and rate-sensitive industry. That disagreement has kept COMP a structurally shorted name for months, but the abruptness of this week's short-interest step-up and the options spike suggest the debate has sharpened specifically into the November 6 report.
Institutional ownership shows FMR with 14.2% and Vanguard entities collectively close to 13%, both adding modestly at the margin. Castle Hook Partners added a striking 14.5 million shares as of June 30, taking a 2.2% stake. D1 Capital opened a fresh 2% position in the same period. No holder on the 13D/G register carries activist intent: all filings are passive 13G designations, and the disclosure notes that stakes are as last disclosed around the 5% threshold, and a holder dropping below 5% may not file again. Insider activity in the 90-day window has been dominated by RSU-related mechanics: the CFO and Chief Legal Officer exercised awards and surrendered shares for tax in mid-September. CEO Robert Reffkin sold small tranches in July and August under a pre-arranged 10b5-1 plan. Discretionary conviction buying from the board is absent.
The last earnings print, on August 4, produced a 9.2% single-day gain, a sharp beat that prompted a cluster of target upgrades. The stock has since given back all of that move and more, falling 16% in the month through mid-October. What to watch in the days ahead is whether the short interest acceleration stalls or extends further into the November 6 report, and whether the put/call ratio's spike on Tuesday was a one-session event or the beginning of a sustained rotation toward protective positioning.
See the live data behind this article on ORTEX.
Open COMP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
